230 related articles for article (PubMed ID: 3030201)
1. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
Pollak R; Barber PL; Prusak BF; Mozes MF
Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
[TBL] [Abstract][Full Text] [Related]
2. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ
Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352
[TBL] [Abstract][Full Text] [Related]
3. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation.
Smiley ML; Wlodaver CG; Grossman RA; Barker CF; Perloff LJ; Tustin NB; Starr SE; Plotkin SA; Friedman HM
Transplantation; 1985 Aug; 40(2):157-61. PubMed ID: 2992130
[TBL] [Abstract][Full Text] [Related]
4. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
5. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression.
Johnson PC; Lewis RM; Golden DL; Oefinger PE; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Jan; 45(1):116-21. PubMed ID: 2827353
[TBL] [Abstract][Full Text] [Related]
6. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
[TBL] [Abstract][Full Text] [Related]
7. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
Chou SW; Norman DJ
Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917
[TBL] [Abstract][Full Text] [Related]
8. The transplanted kidney as a source of cytomegalovirus infection.
Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA
N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.
Grundy JE; Lui SF; Super M; Berry NJ; Sweny P; Fernando ON; Moorhead J; Griffiths PD
Lancet; 1988 Jul; 2(8603):132-5. PubMed ID: 2899189
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection and graft rejection in renal transplantation.
Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
[TBL] [Abstract][Full Text] [Related]
13. Impact of cytomegalovirus serology on graft survival in living related kidney transplantation: implications for donor selection.
Schnitzler MA; Woodward RS; Brennan DC; Spitznagel EL; Dunagan WC; Bailey TC
Surgery; 1997 May; 121(5):563-8. PubMed ID: 9142156
[TBL] [Abstract][Full Text] [Related]
14. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
[TBL] [Abstract][Full Text] [Related]
15. Viral infections in renal transplant donors and their recipients: a prospective study.
Balfour HH; Slade MS; Kalis JM; Howard RJ; Simmons RL; Najarian JS
Surgery; 1977 May; 81(5):487-92. PubMed ID: 191948
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity.
Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM
Transplantation; 1987 Feb; 43(2):187-93. PubMed ID: 3027930
[TBL] [Abstract][Full Text] [Related]
17. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
[TBL] [Abstract][Full Text] [Related]
18. A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.
Vincenti F; Budde K; Merville P; Shihab F; Ram Peddi V; Shah M; Wyburn K; Cassuto-Viguier E; Weidemann A; Lee M; Flegel T; Erdman J; Wang X; Lademacher C
Am J Transplant; 2018 Dec; 18(12):2945-2954. PubMed ID: 29745007
[TBL] [Abstract][Full Text] [Related]
19. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]